$2.56
-0.095-3.58%
In chiusura: Nov 17, 4:00 PM EST

Apyx Medical (APYX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-0.04 | $-0.09 | 55.6 % |
| Q2 | Aug 6, 2026 | $-0.07 | $-0.09 | 22.2 % |
| Q1 | May 7, 2026 | $-0.05 | $-0.11 | 54.5 % |
| Q4 | Mar 10, 2026 | $-0.03 | $-0.06 | 50.0 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $14.03M | $13.36M | 5.01 % |
| Q2 | Aug 6, 2026 | $13.88M | $13.33M | 4.19 % |
| Q1 | May 7, 2026 | $12.49M | $10.97M | 13.9 % |
| Q4 | Mar 10, 2026 | $19.16M | $19.13M | 0.17 % |
Apyx Medical (APYX) ha pubblicato l'ultima guidance il novembre 5, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $59M - $60M per il periodo.
Rispetto alle previsioni precedenti, Apyx Medical ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Apyx Medical ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Apyx Medical. 25
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.09 | $-0.09 | $-0.11 | $-0.06 |
| Actual | $-0.04 | $-0.07 | $-0.05 | $-0.03 |
| Surprise | +55.6% | +22.2% | +54.5% | +50.0% |
| Revenue | ||||
| Estimate | $13.4M | $13.3M | $11.0M | $19.1M |
| Actual | $14.0M | $13.9M | $12.5M | $19.2M |
| Surprise | +5.01% | +4.19% | +13.9% | +0.17% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.04 | $-0.06 | $-0.06 | $-0.06 |
| Revenue | ||||
| Consensus | $19.2M | $13.6M | — | — |